Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL10P13, or ribosomal protein L10 pseudogene 13, is a processed pseudogene in the human genome related to the gene encoding 60S ribosomal protein L10. Unlike the functional RPL10 gene—which encodes a component of the large (60S) ribosomal subunit involved in protein synthesis[3][1]—RPL10P13 does not encode a protein and is not involved in ribosome function or known biological processes. Pseudogenes like RPL10P13 may arise via retrotransposition or gene duplication but typically lack regulatory elements necessary for expression, and are not considered functional or therapeutic targets[6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L10 pseudogene 13 (RPL10P13).